Researchers

Daan Van Aalten 850x850

Daan van Aalten

Professor

Department of Molecular Biology and Genetics - Cellular Health, Intervention, and Nutrition

Daan van Aalten is Professor at Aarhus University, Denmark. Originally graduated as a chemist (1994) followed by a biocomputing PhD (1997), Daan has been working on the interface between cell signalling and glycobiology since joining Dundee as a PI (1999) using a multidisciplinary approach covering the spectrum from synthetic chemistry to genetics. Daan’s work in O-GlcNAc field has included development of chemical biology tools, uncovering novel molecular/biological mechanisms and development of animal models. Following a recent move to Aarhus university his lab now focuses on the dissection of an O-GlcNAc transferase intellectual disability syndrome. 

Links and key research papers

Lance Wells

Lance Wells​

Associate Director of the CMM, Distinguished Research Professor, GRA Distinguished Investigator

Complex Carbohydrate Research Center, University of Georgia

Dr. Wells received his B.S. in Chemistry, with a minor in Psychology, in 1991 from the Georgia Institute of Technology, and after spending two years working at the Microchemical Facility, his Ph.D. in Biochemistry and Molecular Biology in 1998 from the Emory University School of Medicine. A postdoctoral research fellowship at the Johns Hopkins School of Medicine in Biological Chemistry followed, which was supported by a National Research Service Award from the National Cancer Institute of the NIH. Dr. Wells joined the CCRC in August of 2003. Full publications: 98.
 
Using a combination of methodologies, including mass spectrometry, protein biochemistry, cell biology, genetics, proteomics, and molecular biology, we study the role of PTMs (primarily O-glycosylation) in a variety of pathophysiological processes including cancer, diabetes, viral infection, neurological disorders, and congenital muscular dystrophy. Our research is aimed at increasing our understanding of how increased functional diversity leads to finer control of biological processes. The hope is that by understanding the role of PTMs, we will not only more accurately describe fundamental biological processes but will also elucidate novel therapeutic targets in disease states where these processes have become dysregulated.

Links and key research papers

Stephanie Olivier-Van Stichelen, PhD

Stephanie Olivier-Van Stichelen, PhD

Assistant professor in Biochemistry and OBGYN

Medical College of Wisconsin

Dr. Olivier-Van Stichelen received her PhD in Biochemistry from the University of Lille, France in 2012, where she studied the nutrient-sensing O-GlcNAcylation in colorectal cancer development. After completing her degree, she was appointed as a post-doctoral Fellow at the National Institute of Health, Bethesda, MD, USA. In this lab, Dr. Olivier-Van Stichelen worked on different aspects of O-GlcNAcylation during development, including X-inactivation of the O-GlcNAc Transferase gene, brain O-GlcNAcase function in mouse KO models and the impact of sugar and artificial sweeteners consumption during pregnancy on the development of metabolic homeostasis.

Dr. Olivier-Van Stichelen established her lab at the Medical College of Wisconsin in 2019 at the crossroads of sweeteners, pregnancy, development, and metabolism. Notably, her lab has developed several mouse models for studying O-GlcNAcylation and created the O-GlcNAc database, the reference catalog of O-GlcNAcylated proteins for all species. 

Some of the current lab projects include studies of (i) O-GlcNAcylation in the pathophysiology of the pituitary gland, (ii) O-GlcNAc transferase’s function in the sexual dimorphism of Gestational Diabetes, and (iii) artificial sweeteners’ impact on detoxification transporters.

Links and key research papers

Gerald Hart

Gerald Hart

Professor and GRA Eminent Scholar Member of the Complex Carbohydrate Research Center

Complex Carbohydrate Research Center, University of Georgia​

Dr. Hart’s research career began in 1971, focusing on glycoconjugates. He has conducted pioneering studies on cell surface heparan sulfate proteoglycans and the roles of sulfated glycosaminoglycans and hyaluronic acids in corneal transparency. His work also includes the early characterization of proteoglycan sulfotransferases, revealing key insights into the N-linked biosynthetic pathway and the regulation of protein glycosylation.

In the early 1980s, Dr. Hart’s laboratory discovered O-linked N-acetylglucosamine (O-GlcNAc) modification of nuclear and cytoplasmic proteins. His team has published over 200 papers on O-GlcNAcylation, identifying the enzymes that control its cycling and its interplay with phosphorylation. These studies have shown how O-GlcNAcylation regulates various cellular processes, including signaling, transcription, translation, and mitochondrial functions.

Dr. Hart founded the journal Glycobiology in 1989, serving as Editor-In-Chief until 2001. He currently holds editorial roles at the Journal of Biological Chemistry and Molecular and Cellular Proteomics. His accolades include the International Glycoconjugate Organization Award, the Karl Meyer Award, the Presidents Innovator Award, the Herbert Tabor Award, and the Yamakawa Award. He has also served as President of both the International Glycoconjugate Organization and the American Society of Biochemistry and Molecular Biology.

Dr. Hart’s current research focuses on the roles of O-GlcNAcylation in cancer, particularly its impact on β-catenin in WNT signaling and epithelial-mesenchymal transition. His collaboration with Dr. Michael Pierce explores how O-GlcNAcylation influences tumor cell suppression of the immune system.

Links and key research papers

Natasha E. Zachara, PhD

Natasha E. Zachara, PhD

Associate Professor of Biological Chemistry

Johns Hopkins School of Medicine Faculty

Dr. Natasha Zachara is an associate professor of Biological Chemistry and Oncology at the Johns Hopkins School of Medicine. Her research focuses on identifying the molecular mechanisms by which the sugar O-GlcNAc prevents cyrotoxicity, determining how cells regulate O-GlcNAc during times of stress, and how the O-GlcNAc-mediated stress response can be harnessed to reduce tissue death.

Dr. Zachara received her undergraduate degree in biotechnology (with honors) from Macquarie University in Sydney, Australia. Her dissertation, completed at Macquarie University, focused on developing new technologies to map and quantify site-specific changes in protein glycosylation. She completed postdoctoral studies in glycobiology at the Johns Hopkins University School of Medicine. Dr. Zachara joined the Johns Hopkins faculty in 2007.

Dr. Zachara serves as the director of the K12 training program Immersive Training in the Glycosciences. She is a member of several professional organizations, including the American Society of Biochemists and Molecular Biologists, and serves on the editorial board of the Journal of Biological Chemistry. Her work has been recognized with numerous awards and honors, including the Lorne Protein Structure and Function Young Scientist Award in 2006.

Links and key research papers

  • Groves JA, Maduka AO, O’Meally RN, Cole RN, Zachara NE. Fatty acid synthase inhibits the O-GlcNAcase during oxidative stress. J Biol Chem. 2017 Apr 21;292(16):6493-6511. doi: 10.1074/jbc.M116.760785. Epub 2017 Feb 23. PMID: 28232487; PMCID: PMC5399103
  • Kazemi Z., Chang H., Haserodt S. K., McKen C., Zachara N.E. (2010) O-GlcNAc Regulates Stress-Induced Heat Shock Protein Expression in a GSK-3? Dependent Manner. J. Biol. Chem., 285, 39096-39107

  • Lee A, Miller D, Henry R, Paruchuri VD, O’Meally RN, Boronina T, Cole RN, Zachara NE. Combined Antibody/Lectin Enrichment Identifies Extensive Changes in the O-GlcNAc Sub-proteome upon Oxidative Stress. J Proteome Res. 2016 Dec 2;15(12):4318-4336. doi: 10.1021/acs.jproteome.6b00369. Epub 2016 Oct 14. PMID: 27669760

  • All publications